Showing results (251-260 of 565) with videos related to
Sort By:
Pageof 57
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 15, 2022
Risk Factors for Incident Inflammatory Bowel Disease According to Disease PhenotypeEmily W Lopes, Paul Lochhead, Kristin E Burke, et al.Gut|May 24, 2012
Oral contraceptives, reproductive factors and risk of inflammatory bowel diseaseHamed Khalili, Leslie M Higuchi, Ashwin N Ananthakrishnan, et al.ACG Case Reports Journal|September 14, 2016
Primary Adenocarcinoma of an Ileostomy in Crohn's DiseaseKevin Liu, Meena A Prasad, Amy Lo, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 16, 2011
Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysisAlexander C Ford, Khurram J Khan, William J Sandborn, et al.Inflammatory Bowel Diseases|February 18, 2020
Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-AnalysisShadi Hamdeh, Muhammad Aziz, Osama Altayar, et al.Inflammatory Bowel Diseases|October 18, 2013
Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's diseaseAtsushi Sakuraba, Maria L Annunziata, Russell D Cohen, et al.Journal of Crohn'S & Colitis|July 24, 2014
In vitro sensitivity assays and clinical response to glucocorticoids in patients with inflammatory bowel diseaseJoseph C Maranville, Dejan Micic, Stephen B Hanauer, et al.Inflammatory Bowel Diseases|January 8, 2015
Measures of obesity and risk of Crohn's disease and ulcerative colitisHamed Khalili, Ashwin N Ananthakrishnan, Gauree G Konijeti, et al.BMC Gastroenterology|January 7, 2019
Cancer risk in microscopic colitis: a retrospective cohort studyAlexander Levy, Nienke Z Borren, Benjamin Maxner, et al.Inflammatory Bowel Diseases|May 3, 2018
Genetic Markers Predict Primary Nonresponse and Durable Response to Anti-Tumor Necrosis Factor Therapy in Ulcerative ColitisKristin E Burke, Hamed Khalili, John J Garber, et al.Pageof 57